University of New Mexico
Albuquerque, New Mexico, 87131, United States
NCT Number: NCT04520191
Novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) OR COVID-19 related Addition: The aim of this addition activity is to track the impact of the COVID-19 epidemic on participants with diabetes and chronic kidney disease (CKD). Investigators have modified the original HBKC Study protocol to expand data currently collected from study participants to include data in the following domains linked to the COVID-19 epidemic:
symptoms of COVID-19 disease, access to healthcare, and impact on health related behaviors (such as medication adherence, physical activity, dietary behaviors, smoking, and alcohol use).
Looking for future studies?
Notify Me21 year–80 year
All sexes
Observational
Albuquerque, New Mexico, 87131, United States
Investigators will administer a survey by phone or mail to all participants screened for diabetes and chronic kidney disease in the original HBKC study protocol. The survey will address to the following aims:
Aim 1. Develop a phone-based and or mail based survey to understand the impact of COVID19 on patient-reported outcomes for adults with diabetes and CKD.
Aim 2. Test the feasibility and acceptability of this phone-based and or mail based survey in the HBKC cohort.
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: six months
Document COVID-19 disruptions in normal health care check-ups, transportation, economic status, and access to food and water.
University of New Mexico
Other
Home-based Kidney Care in Native Americans of New Mexico (HBKC) - COVID-19 Related Disruption in Health and Health Care
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04709120
Arrhythmias, Cardiac, Atrial Fibrillation
Moscow, Russia
View Trial DetailsNCT04492384
Body Weight, CKD
Moscow, Russia
View Trial DetailsNCT06094920
Albuminuria, CKD
Almelo, Overijssel, Netherlands
View Trial DetailsNCT06374043
Albuminuria, CKD
Almelo, Netherlands
View Trial Details